⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18748729 | 1.00 | ALDH1A1 (0.44) | — | |
| SCHEMBL16877890 | 0.93 | — | — | |
| SCHEMBL6203888 | 0.90 | — | — | |
| SCHEMBL14116483 | 0.87 | — | — | |
| SCHEMBL10505641 | 0.86 | TTR (0.42) | — | |
| SCHEMBL39457 | 0.86 | — | — | |
| SCHEMBL6776258 | 0.86 | — | — | |
| SCHEMBL8667852 | 0.86 | TTR (0.42) | — | |
| SCHEMBL14583489 | 0.85 | ALDH1A1 (0.44) | — | |
| SCHEMBL19484367 | 0.84 | TTR (0.38) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1148 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260097015-A1 | EXTENDED RELEASE FORMULATIONS COMPRISING SUBSTITUTED INDAZOLE PROPIONIC ACID DERIVATIVE COMPOUNDS AND USES THEREOF | PFIZER (US) | 2026-04-09 | — | — | US | disclosed |
| EP-4688750-A1 | SUBSTITUTED INDAZOLE PROPIONIC ACID DERIVATIVE COMPOUNDS AND USES THEREOF AS AMPK ACTIVATORS | Pfizer Inc. (US) | 2026-02-11 | — | — | EP | disclosed |
| EP-4634169-A1 | 3-FLUORO-4-HYDROXYBENZMIDE-CONTAINING INHIBITORS AND/OR DEGRADERS AND USES THEREOF | Pfizer Inc. (US) | 2025-10-22 | — | — | EP | disclosed |
| US-12447153-B2 | HER2 mutation inhibitors | PFIZER INC. (US) | 2025-10-21 | — | — | US | disclosed |
| US-20250235510-A1 | COMBINATION THERAPY USING GLUCOSE-DEPENDENT INSULINOTROPIC POLYPEPTIDE RECEPTOR ANTAGONIST COMPOUNDS AND GLP-1 RECEPTOR AGONIST PEPTIDES | PFIZER INC. (US) | 2025-07-24 | — | — | US | disclosed |
| US-20250235460-A1 | COMBINATION THERAPY USING GLUCOSE-DEPENDENT INSULINOTROPIC POLYPEPTIDE RECEPTOR ANTAGONIST COMPOUNDS AND GLP-1 RECEPTOR AGONIST COMPOUNDS | PFIZER INC. (US) | 2025-07-24 | — | — | US | disclosed |
| US-20250109143-A1 | KLF2 INDUCING DEUTERATED COMPOUNDS AND USES THEREOF | RIPARIAN PHARMACEUTICALS, INC. (US) | 2025-04-03 | — | — | US | disclosed |
| WO-2025032440-A1 | KLF2 INDUCING COMPOUNDS AND USES THEREOF | PFIZER INC. (US) | 2025-02-13 | — | — | WO | disclosed |
| WO-2024237816-A1 | NOVEL AZABICYCLOHEXANE DERIVATIVES | ОБЩЕСТВО С ОГРАНИЧЕННОЙ ОТВЕТСТВЕННОСТЬЮ "ПРОМОМЕД РУС" | 2024-11-21 | — | — | WO | disclosed |
| WO-2024209363-A1 | SUBSTITUTED INDAZOLE PROPIONIC ACID DERIVATIVE COMPOUNDS AND USES THEREOF AS AMPK ACTIVATORS | PFIZER INC. (US) | 2024-10-10 | — | — | WO | disclosed |
| WO-2005013958-A1 | HISTONE DEACETYLASE INHIBITORS AS IMMUNOSUPPRESSANTS | NOVARTIS AG (CH) | 2005-02-17 | — | — | WO | disclosed |
| WO-2005014574-A1 | SUBSTITUTED LACTAMS AND THEIR USE AS ANTI-CANCER AGENTS | NOVARTIS AG (CH) | 2005-02-17 | — | — | WO | disclosed |
| US-20050032899-A1 | Cyclooxygenase-2 inhibitor/histone deacetylase inhibitor combination | NOVARTIS AG (CH) | 2005-02-10 | — | — | US | disclosed |
| US-6833384-B2 | E. g., N-Hydroxy-3-(4-(((2-(1H-indol-3-yl)-ethyl)amino)-amino)methyl)-phenyl)-2E-2 -propenamide; histone deacetylase inhibitors; antiproliferative agents; antitumor agents; anticarcinogenic agents | NOVARTIS AG (CH) | 2004-12-21 | — | — | US | disclosed |
| WO-2004037181-A2 | GLYCINENITRILE-BASED INHIBITORS OF DIPEPTIDYL PEPTIDASE IV AND METHODS | BRISTOL-MYERS SQUIBB COMPANY (US) | 2004-05-06 | — | — | WO | disclosed |
| US-20040024067-A1 | Deacetylase inhibitors | ATHYRIUM OPPORTUNITIES III ACQUISITION LP | 2004-02-05 | — | — | US | disclosed |
| US-20040014743-A1 | 2-(Quinolonyl)-fused heterocycles as androgen receptor modulators | ORTHO-MCNEIL PHARMACEUTICAL, INC. | 2004-01-22 | — | — | US | disclosed |
| US-6552065-B2 | Antiproliferative agents | NOVARTIS AG (CH) | 2003-04-22 | — | — | US | disclosed |
| US-20030018062-A1 | Deacetylase inhibitors | SECURA BIO, INC. | 2003-01-23 | — | — | US | disclosed |
| US-4228252-A | STEREOSPECIFIC ADDITIVE OF A SULFIDE AND ETHER COMPOUND | ATO CHIMIE (FR) | 1980-10-14 | — | — | US | disclosed |